{"log_id": 5090760763537125254, "direction": 0, "words_result_num": 41, "words_result": [{"probability": {"variance": 3e-06, "average": 0.998734, "min": 0.994281}, "location": {"width": 353, "top": 166, "height": 55, "left": 419}, "words": "阿昔洛韦片说明书"}, {"probability": {"variance": 0.000117, "average": 0.994999, "min": 0.970857}, "location": {"width": 117, "top": 233, "height": 25, "left": 177}, "words": "【药品名称】"}, {"probability": {"variance": 5.5e-05, "average": 0.994106, "min": 0.976081}, "location": {"width": 194, "top": 268, "height": 26, "left": 170}, "words": "通用名:阿昔洛韦片"}, {"probability": {"variance": 0.000133, "average": 0.991352, "min": 0.967663}, "location": {"width": 261, "top": 306, "height": 25, "left": 170}, "words": "英文名: Aciclovir Tablets"}, {"probability": {"variance": 0.000156, "average": 0.989414, "min": 0.961849}, "location": {"width": 255, "top": 343, "height": 25, "left": 169}, "words": "汉语拼音: Axiluowei Pian"}, {"probability": {"variance": 0.001269, "average": 0.985915, "min": 0.84351}, "location": {"width": 618, "top": 375, "height": 31, "left": 170}, "words": "本品主要成分为阿昔洛韦,其化学名为9-(2-羟乙氧甲基)鸟嘌呤"}, {"probability": {"variance": 0, "average": 0.999491, "min": 0.998508}, "location": {"width": 130, "top": 413, "height": 26, "left": 171}, "words": "其化学结构式"}, {"probability": {"variance": 0, "average": 0.869573, "min": 0.869573}, "location": {"width": 36, "top": 506, "height": 22, "left": 606}, "words": " OE"}, {"probability": {"variance": 0.007321, "average": 0.94256, "min": 0.758353}, "location": {"width": 154, "top": 626, "height": 24, "left": 171}, "words": "分子式: CAH,N,O"}, {"probability": {"variance": 0.000299, "average": 0.99143, "min": 0.939749}, "location": {"width": 148, "top": 659, "height": 26, "left": 170}, "words": "分子量:225.21"}, {"probability": {"variance": 0.000163, "average": 0.99483, "min": 0.956598}, "location": {"width": 207, "top": 690, "height": 26, "left": 177}, "words": "【性状】本品为白色片"}, {"probability": {"variance": 0.001715, "average": 0.958127, "min": 0.916713}, "location": {"width": 96, "top": 660, "height": 48, "left": 660}, "words": "以岭"}, {"probability": {"variance": 1e-06, "average": 0.998938, "min": 0.997143}, "location": {"width": 116, "top": 726, "height": 23, "left": 177}, "words": "【药理毒理】"}, {"probability": {"variance": 4e-06, "average": 0.997236, "min": 0.995101}, "location": {"width": 88, "top": 759, "height": 24, "left": 170}, "words": "药理作用"}, {"probability": {"variance": 0.002565, "average": 0.985697, "min": 0.655404}, "location": {"width": 902, "top": 781, "height": 38, "left": 171}, "words": "本品为合成的核苷类抗病毒药,体内和体外对单纯疱疹病毒I型(HSV-1)、II型(HSV-2)及水痘"}, {"probability": {"variance": 0.025687, "average": 0.920894, "min": 0.428665}, "location": {"width": 970, "top": 810, "height": 45, "left": 114}, "words": "带状泡疹病毒(Vzv)均有抑制作用。细胞培养结果表明本品对抑制HSV病毒的作用最强,其次为HSV-2"}, {"probability": {"variance": 0.021754, "average": 0.873812, "min": 0.667778}, "location": {"width": 114, "top": 859, "height": 25, "left": 115}, "words": "和VZV病毒"}, {"probability": {"variance": 0.005497, "average": 0.97706, "min": 0.509827}, "location": {"width": 911, "top": 880, "height": 38, "left": 172}, "words": "由于本品对由HSV和VZV编码的胸苷激酶(TK)具有亲和力,使得其具有高选择性的抑制作用。此"}, {"probability": {"variance": 0.000247, "average": 0.99331, "min": 0.907205}, "location": {"width": 969, "top": 913, "height": 40, "left": 115}, "words": "类病毒酶将阿昔洛韦转化成阿昔洛韦单磷酸盐,即核苷类似物。单磷酸盐进一步被细胞中的鸟苷酸激酶转"}, {"probability": {"variance": 0.000796, "average": 0.991716, "min": 0.848643}, "location": {"width": 968, "top": 946, "height": 40, "left": 115}, "words": "化成二磷酸盐,再通过细胞中的多种酶转变为三磷酸盐。在体外,阿昔洛韦三磷酸盐中止疱疹病毒DNA的"}, {"probability": {"variance": 0.000148, "average": 0.99496, "min": 0.917865}, "location": {"width": 954, "top": 980, "height": 39, "left": 115}, "words": "复制是由以下三种方式完成:1)竞争性地抑制病毒DNA聚合酶;2)进入并终止延长的病毒DNA链;3)"}, {"probability": {"variance": 0.001038, "average": 0.986539, "min": 0.825977}, "location": {"width": 971, "top": 1016, "height": 36, "left": 115}, "words": "灭活病毒DNA聚合酶。与VZV相比,本品对HSV的抗病毒活性更强,这是因为病毒的胸苷激酶(TK)的磷"}, {"probability": {"variance": 8e-06, "average": 0.996429, "min": 0.991872}, "location": {"width": 127, "top": 1059, "height": 25, "left": 117}, "words": "酸化作用更强"}, {"probability": {"variance": 0, "average": 0.99932, "min": 0.9983}, "location": {"width": 85, "top": 1090, "height": 24, "left": 174}, "words": "毒理研究"}, {"probability": {"variance": 0.00018, "average": 0.995987, "min": 0.912706}, "location": {"width": 913, "top": 1113, "height": 38, "left": 172}, "words": "遗传毒性:进行了16项遗传毒性试验,在4项微生物研究中未见致突变作用;在小鼠淋巴瘤细胞和"}, {"probability": {"variance": 0.000302, "average": 0.993088, "min": 0.910383}, "location": {"width": 967, "top": 1147, "height": 38, "left": 118}, "words": "人淋巴细胞上进行的2项体外细胞遗传试验结果表明,本品具有致突变作用。在5项体外细胞遗传试验(3"}, {"probability": {"variance": 1.4e-05, "average": 0.997632, "min": 0.981576}, "location": {"width": 957, "top": 1179, "height": 40, "left": 119}, "words": "项为中国仓鼠的卵巢细胞,2项为小鼠淋巴瘤细胞)中,未见致突变作用。在免疫功能不全的、正断乳的"}, {"probability": {"variance": 1.6e-05, "average": 0.997357, "min": 0.97585}, "location": {"width": 966, "top": 1212, "height": 40, "left": 119}, "words": "同源的幼鼠给药后所进行的2次体外细胞转化试验中,其中1次结果为阳性,可见细胞从形态上转变为肿"}, {"probability": {"variance": 0.000151, "average": 0.994251, "min": 0.942517}, "location": {"width": 968, "top": 1247, "height": 40, "left": 117}, "words": "瘤细胞,而在另一试验中,则未见同样的结果(原因可能是敏感倍剂量给药时,染色体的损伤无明显变化)"}, {"probability": {"variance": 0.001272, "average": 0.989882, "min": 0.796835}, "location": {"width": 612, "top": 1281, "height": 38, "left": 118}, "words": "小鼠的显性致死试验(在人用剂量的36-73倍剂量下)结果为阴性"}, {"probability": {"variance": 0.002022, "average": 0.980512, "min": 0.74377}, "location": {"width": 910, "top": 1311, "height": 39, "left": 177}, "words": "生殖毒性:小鼠(450mg/Kg/天,P0)和家兔(25mg/Kg/天,SC)试验结果表明本品对其生育能力"}, {"probability": {"variance": 0.003233, "average": 0.983203, "min": 0.703827}, "location": {"width": 960, "top": 1343, "height": 41, "left": 121}, "words": "和生殖功能无影响。小鼠和大鼠的血浆药物浓度分别为人体血药水平的9-18倍和815倍。大鼠和家兔给"}, {"probability": {"variance": 0.003192, "average": 0.975663, "min": 0.721958}, "location": {"width": 968, "top": 1379, "height": 39, "left": 120}, "words": "予更高剂量(50mg/Kg/天,SC,分别为人用水平的11-22倍和16-31倍)时,可降低着床,但不影响同窝"}, {"probability": {"variance": 0.002029, "average": 0.985947, "min": 0.700169}, "location": {"width": 971, "top": 1411, "height": 40, "left": 119}, "words": "仔的大小。大鼠在产前和产后服用本品(50mg/Kg/天,SC),组间平均黄体、总着床位置和活存胎儿等均"}, {"probability": {"variance": 1.3e-05, "average": 0.996586, "min": 0.98847}, "location": {"width": 234, "top": 1451, "height": 33, "left": 120}, "words": "有统计学意义的明显下降"}, {"probability": {"variance": 0.003811, "average": 0.977727, "min": 0.61711}, "location": {"width": 913, "top": 1475, "height": 40, "left": 177}, "words": "犬连续1个月给予本品(50mg/Kg/天,IV,为人用剂量的21-41倍)(血药浓度为人的21-41倍)或"}, {"probability": {"variance": 0.010336, "average": 0.966013, "min": 0.504742}, "location": {"width": 973, "top": 1509, "height": 42, "left": 120}, "words": "连续1年(60mg/Kg/天,P0,为人用剂量的6-12倍),结果均未发现睾丸异常。在给大鼠和犬的更高剂量"}, {"probability": {"variance": 0.000142, "average": 0.993305, "min": 0.955022}, "location": {"width": 276, "top": 1550, "height": 36, "left": 121}, "words": "时,可见睾丸萎缩和精子减少"}, {"probability": {"variance": 0.011499, "average": 0.945933, "min": 0.731469}, "location": {"width": 126, "top": 1539, "height": 27, "left": 1056}, "words": "国家食品王"}, {"probability": {"variance": 1.8e-05, "average": 0.991932, "min": 0.98746}, "location": {"width": 84, "top": 1577, "height": 30, "left": 1093}, "words": "药品批"}, {"probability": {"variance": 2e-06, "average": 0.992116, "min": 0.990636}, "location": {"width": 68, "top": 1610, "height": 31, "left": 1108}, "words": "附件"}], "language": 3}